DE
About
Dominik is a founding partner of Pureos and a co-founder and Executive Chairman of CDR-Life. He is also president of the Swiss Biotech Association. Previously, he was a founder and CEO of ESBATech, which was acquired in 2009 by Alcon (Novartis) for USD 589 million. As a biotech entrepreneur, he raised USD 90 million for ESBATech to develop novel antibody fragments from discovery to maturity, delivering multiple clinically successful products (e.g., Brolucizumab). Dominik obtained his PhD in Molecular Biology from the University of Zurich.
Position in the VCSift Database
- • 3 investors hold the CEO & Co- Founder role in VCSift. Dominik Escher is one of them.
- • 148 investors are based in Zurich, Switzerland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Zurich, Switzerland
Contact Information
linkedin.com/in/••••••••
Find more investors like Dominik
Search Investors